Veeral Desai - 16 Mar 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
16 Mar 2023
Net transactions value
-$1,385,196
Form type
4
Filing time
17 Mar 2023, 16:54:25 UTC
Previous filing
25 Jul 2022
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $180,000 +60,000 +22% $3.00* 336,729 16 Mar 2023 Direct F1, F2
transaction AGL Common Stock Sale $1,565,196 -60,000 -18% $26.09 276,729 16 Mar 2023 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -60,000 -3.5% $0.000000 1,640,000 16 Mar 2023 Common Stock 60,000 $3.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The total was decreased by 1,482 shares as reported in the Form 4 Amendment filed on September 29, 2022.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 These options were granted on April 27, 2017 and vested on September 14, 2021.

Remarks:

Exhibit List: Ex.24 - Power of Attorney